|
PHACTR4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.276800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.585900E-02 |
| Normal-vs-Stage2 |
1.743690E-02 |
| Normal-vs-Stage3 |
1.142750E-03 |
| Normal-vs-Stage4 |
3.830400E-02 |
| Stage1-vs-Stage2 |
2.582000E-01 |
| Stage1-vs-Stage3 |
6.969900E-02 |
| Stage1-vs-Stage4 |
6.814400E-01 |
| Stage2-vs-Stage3 |
8.656400E-01 |
| Stage2-vs-Stage4 |
4.823800E-01 |
| Stage3-vs-Stage4 |
2.672800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.977100E-03 |
| Normal-vs-AfricanAmerican |
7.761900E-03 |
| Normal-vs-Asian |
9.891600E-02 |
| Caucasian-vs-AfricanAmerican |
4.022600E-01 |
| Caucasian-vs-Asian |
6.464600E-03 |
| AfricanAmerican-vs-Asian |
2.444500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.138600E-03 |
| Normal-vs-Female |
8.227600E-02 |
| Male-vs-Female |
7.567900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.947500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.922100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.302000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.135540E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.674800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.142800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.099400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.618200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.424400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.129000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.128400E-02 |
| Normal-vs-Grade 2 |
2.012800E-01 |
| Normal-vs-Grade 3 |
3.196000E-04 |
| Normal-vs-Grade 4 |
3.825800E-04 |
| Grade 1-vs-Grade 2 |
2.044400E-02 |
| Grade 1-vs-Grade 3 |
1.362970E-04 |
| Grade 1-vs-Grade 4 |
3.68510000000599E-05 |
| Grade 2-vs-Grade 3 |
2.880400E-03 |
| Grade 2-vs-Grade 4 |
2.044700E-03 |
| Grade 3-vs-Grade 4 |
4.663400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.111400E-01 |
| Normal-vs-ccB subtype |
1.09270000003825E-06 |
| ccA subtype-vs-ccB subtype |
2.2985999770242E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.016410E-02 |
| Normal-vs-N1 |
1.470850E-01 |
| N0-vs-N1 |
9.075000E-01 |
|
|
